Pulse Biosciences Non Currrent Assets Other Over Time
| PLSE Stock | USD 16.05 0.86 5.09% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Pulse Biosciences Performance and Pulse Biosciences Correlation. Pulse |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulse Biosciences. If investors know Pulse will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulse Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pulse Biosciences is measured differently than its book value, which is the value of Pulse that is recorded on the company's balance sheet. Investors also form their own opinion of Pulse Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pulse Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulse Biosciences' market value can be influenced by many factors that don't directly affect Pulse Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulse Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulse Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulse Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Non Currrent Assets Other Analysis
Compare Pulse Biosciences and related stocks such as InfuSystems Holdings, Repro Med Systems, and Milestone Scientific Non Currrent Assets Other Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INFU | 165.1 K | 590 K | 3 M | 3.9 M | 2.5 M | 2.5 M | 1.9 M | 1.7 M | 1.7 M | 1.5 M | 1.7 M | (39.8 M) | (39.4 M) | 41 M | 44.7 M | 46.9 M |
| KRMD | 50 K | 28.2 K | 60.4 K | 31.1 K | 31.1 K | 31.1 K | 31.5 K | 9.9 K | 19.6 K | 19.6 K | 19.8 K | 19.8 K | 102.6 K | 99 K | 89.1 K | 45.2 K |
| MLSS | 800 K | 27.8 K | 2.5 M | 12.9 K | 14.7 K | 17.4 K | 17.4 K | 26.9 K | 26.9 K | 35.9 K | 24.1 K | 24.1 K | 24.1 K | 24.1 K | 21.7 K | 20.6 K |
| PDEX | 200 K | (108.2 M) | 813 K | (38 K) | 16 K | 80 K | 71 K | 68 K | 40 K | 42 K | 67 K | 42 K | 34 K | 1.6 M | 1.4 M | 1.5 M |
| OSUR | 700 K | 47 K | 124 K | 729 K | 1.2 M | 1.7 M | 2.3 M | 2 M | 2.6 M | 2.3 M | 6.6 M | 10.5 M | 12.4 M | 1.2 M | 1.5 M | 2 M |
| NYXH | 70 K | 70 K | 70 K | 70 K | 70 K | 70 K | 70 K | 70 K | 68 K | 78 K | (1000) | 164 K | 173 K | 47.3 M | 54.4 M | 57.1 M |
| LMAT | 6.3 M | 431 K | 172 K | 167 K | 170 K | 168 K | 163 K | 178 K | 194 K | 259 K | 909 K | 568 K | 991 K | 3.7 M | 4.9 M | 5.1 M |
| UTMD | 100 K | (451 K) | (451 K) | (363 K) | (363 K) | (363 K) | (393 K) | (3.1 M) | 38.9 M | 54.9 M | (49.5 M) | (2.1 M) | (1.5 M) | (1.0) | (1.15) | (1.09) |
| AKYA | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 2.5 M | 3.2 M | 3.1 M | 2.2 M | 2.6 M | 2.7 M |
| ATRC | 424.6 K | 270.6 K | 430 K | 218 K | 186 K | 323 K | 321 K | 676 K | 495 K | 705 K | 440 K | 955 K | 2 M | 2.2 M | 2.9 M | 3 M |
| ICUI | 100 K | 135.6 M | 135.6 M | 135.6 M | 135.6 M | 135.6 M | 135.6 M | 38.1 M | 40.4 M | 49 M | 55.5 M | 63.7 M | 105.5 M | 88.2 M | 68.1 M | 71.5 M |
| HAE | 12.6 M | 222.3 M | 608 M | 619.8 M | 593.2 M | 20 M | 16.4 M | 16 M | 16.2 M | 66.3 M | 76.9 M | 63.2 M | 107 M | 81.1 M | 93.3 M | 99.2 M |
Pulse Biosciences and related stocks such as InfuSystems Holdings, Repro Med Systems, and Milestone Scientific Non Currrent Assets Other description
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.My Equities
My Current Equities and Potential Positions
| Pulse Biosciences | PLSE |
Specialization | Health Care, Health Care Equipment & Services |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 16.05
Check out Pulse Biosciences Performance and Pulse Biosciences Correlation. For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Pulse Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.